Evofosfamide Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RNXT | D | RenovoRx, Inc. | 2.20 | |
MTEM | F | Molecular Templates, Inc. | 1.73 | |
CNSP | F | CNS Pharmaceuticals, Inc. | 0.90 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Cancer Treatment
Oncology
Solid Tumors
Biopharmaceutical
Blastoma
Brain Tumor
Central Nervous System Tumors
Chemical Elements
Clinical Medicine
Drugs
Gastrointestinal Cancer
Gemcitabine
Glioblastoma
Locally Advanced Pancreatic Cancer
Lymphoma
Medicine
Nitrogen Mustards
Oncolytics Biotech
Oxygen
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Cancer Treatment
Oncology
Solid Tumors
Biopharmaceutical
Blastoma
Brain Tumor
Central Nervous System Tumors
Chemical Elements
Clinical Medicine
Drugs
Gastrointestinal Cancer
Gemcitabine
Glioblastoma
Locally Advanced Pancreatic Cancer
Lymphoma
Medicine
Nitrogen Mustards
Oncolytics Biotech
Oxygen
- Evofosfamide
Evofosfamide (INN, USAN; formerly known as TH-302) is an investigational hypoxia-activated prodrug that is in clinical development for cancer treatment. The prodrug is activated only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia.Evofosfamide is being evaluated in clinical trials for the treatment of multiple tumor types as a monotherapy and in combination with chemotherapeutic agents and other targeted cancer drugs.
Dec 2015 : two Phase 3 trials fail, Merck will not apply for a license
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles